Search Results | Clinical Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response

Clin Cancer Res (2022) 28 (4): 697–707.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-3231

Published: 02 December 2021

View article

Includes: Supplementary data

Journal Articles

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8

Martin Filipits, Margaretha Rudas, Verena Kainz, Christian F. Singer, Florian Fitzal, Zsuzsanna Bago-Horvath, Richard Greil, Marija Balic, Peter Regitnig, Stefan Halper, Wolfgang Hulla, Daniel Egle, Stephen Barron, Tony Loughman, Des O'Leary, William M. Gallagher, Dominik Hlauschek, Michael Gnant, Peter Dubsky

Clin Cancer Res (2021) 27 (21): 5931–5938.

DOI: https://doi.org/10.1158/1078-0432.CCR-21-1023

Published: 01 November 2021

View article

Includes: Supplementary data

Journal Articles

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the ABCSG Trial 5

Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F. Singer, Richard Greil, Marija Balic, Sigurd F. Lax, Werner Kwasny, Wolfgang Hulla, Michael Gnant, Martin Filipits

Clin Cancer Res (2020) 26 (21): 5682–5688.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-0673

Published: 02 November 2020

View article

Journal Articles

Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer

Ivana Sestak, Martin Filipits, Richard Buus, Margaretha Rudas, Marija Balic, Michael Knauer, Ralf Kronenwett, Florian Fitzal, Jack Cuzick, Michael Gnant, Richard Greil, Mitch Dowsett, Peter Dubsky

Clin Cancer Res (2020) 26 (17): 4682–4687.

DOI: https://doi.org/10.1158/1078-0432.CCR-20-0260

Published: 01 September 2020

View article

Journal Articles

Prediction of Distant Recurrence Using EndoPredict Among Women with ER⁺, HER2⁻ Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only

Martin Filipits, Peter Dubsky, Margaretha Rudas, Richard Greil, Marija Balic, Zsuzsanna Bago-Horvath, Christian F. Singer, Dominik Hlauschek, Krystal Brown, Ryan Bernhisel, Ralf Kronenwett, Johnathan M. Lancaster, Florian Fitzal, Michael Gnant

Clin Cancer Res (2019) 25 (13): 3865–3872.

DOI: https://doi.org/10.1158/1078-0432.CCR-19-0376

Published: 01 July 2019

View article

Includes: Supplementary data

Journal Articles

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Clin Cancer Res (2019) 25 (10): 2975–2987.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-3160

Published: 15 May 2019

View article

Includes: Supplementary data

Journal Articles

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Elisabeth S. Bergen, Anna S. Berghoff, Mela Medjedovic, Margaretha Rudas, Florian Fitzal, Zsuzsanna Bago-Horvath, Karin Dieckmann, Robert M. Mader, Ruth Exner, Michael Gnant, Christoph C. Zielinski, Guenther G. Steger, Matthias Preusser, Rupert Bartsch

Clin Cancer Res (2019) 25 (9): 2737–2744.

DOI: https://doi.org/10.1158/1078-0432.CCR-18-1968

Published: 01 May 2019

View article

Includes: Supplementary data

Journal Articles

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

Martin Filipits, Urania Dafni, Michael Gnant, Varvara Polydoropoulou, Margaret Hills, Astrid Kiermaier, Evandro de Azambuja, Denis Larsimont, Federico Rojo, Giuseppe Viale, Masakazu Toi, Nadia Harbeck, Kathleen I. Prichard, Richard D. Gelber, Phuong Dinh, Dimitrios Zardavas, Brian Leyland-Jones, Martine J. Piccart-Gebhart, Mitch Dowsett

Clin Cancer Res (2018) 24 (13): 3079–3086.

DOI: https://doi.org/10.1158/1078-0432.CCR-17-3473

Published: 01 July 2018

View article

Includes: Supplementary data

Journal Articles

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer

Christian F. Singer, Yen Y. Tan, Florian Fitzal, Guenther G. Steger, Daniel Egle, Angelika Reiner, Margaretha Rudas, Farid Moinfar, Christine Gruber, Edgar Petru, Rupert Bartsch, Kristina A. Tendl, David Fuchs, Michael Seifert, Ruth Exner, Marija Balic, Zsuzsanna Bago-Horvath, Martin Filipits, Michael Gnant

Clin Cancer Res (2017) 23 (14): 3676–3683.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-2373

Published: 13 July 2017

View article

Includes: Supplementary data

Journal Articles

Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.

Anna Bachmayr-Heyda, Stefanie Aust, Katharina Auer, Peter Borossay, Nina Pecha, Ugo Cavallaro, Ioana Braicu, Sarah Igidbashian, Costanza Savino, Franchi Dorella, Jalid Sehouli, Sonia Zaafrani, Florian Fitzal, Christian Singer, Michael Gnant, Robert Zeillinger, Dietmar Pils

Clin Cancer Res (2016) 22 (2_Supplement): B28.

DOI: https://doi.org/10.1158/1557-3265.OVCA15-B28

Published: 15 January 2016

View article

Journal Articles

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

Clin Cancer Res (2014) 20 (5): 1298–1305.

DOI: https://doi.org/10.1158/1078-0432.CCR-13-1845

Published: 02 March 2014

View article

Includes: Supplementary data

Journal Articles

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Matthew P. Goetz, Vera J. Suman, Tanya L. Hoskin, Michael Gnant, Martin Filipits, Stephanie L. Safgren, Mary Kuffel, Raimund Jakesz, Margaretha Rudas, Richard Greil, Otto Dietze, Alois Lang, Felix Offner, Carol A. Reynolds, Richard M. Weinshilboum, Matthew M. Ames, James N. Ingle

Clin Cancer Res (2013) 19 (2): 500–507.

DOI: https://doi.org/10.1158/1078-0432.CCR-12-2153

Published: 16 January 2013

View article

Journal Articles

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer

Zsuzsanna Bago-Horvath, Margaretha Rudas, Peter Dubsky, Raimund Jakesz, Christian F. Singer, Ralf Kemmerling, Richard Greil, Andrea Jelen, Gerhard Böhm, Zerina Jasarevic, Anton Haid, Christine Gruber, Sabine Pöstlberger, Martin Filipits, Michael Gnant

Clin Cancer Res (2011) 17 (24): 7828–7834.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-1846

Published: 18 December 2011

View article

Journal Articles

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Clin Cancer Res (2011) 17 (18): 6012–6020.

DOI: https://doi.org/10.1158/1078-0432.CCR-11-0926

Published: 14 September 2011

View article

Includes: Supplementary data

Journal Articles

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Clin Cancer Res (2008) 14 (7): 2082–2087.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-2068

Published: 01 April 2008

View article

Journal Articles

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Rupert Bartsch, Catharina Wenzel, Gabriela Altorjai, Ursula Pluschnig, Robert M. Mader, Michael Gnant, Raimund Jakesz, Margaretha Rudas, Christoph C. Zielinski, Guenther G. Steger

Clin Cancer Res (2007) 13 (15): 4435–4439.

DOI: https://doi.org/10.1158/1078-0432.CCR-06-3050

Published: 01 August 2007

View article

Journal Articles

Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

Anton Stift, Monika Sachet, Rubina Yagubian, Clemens Bittermann, Peter Dubsky, Christine Brostjan, Roswitha Pfragner, Bruno Niederle, Raimund Jakesz, Michael Gnant, Josef Friedl

Clin Cancer Res (2004) 10 (9): 2944–2953.

DOI: https://doi.org/10.1158/1078-0432.CCR-03-0698

Published: 06 May 2004

View article

Journal Articles

Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen

Thomas Bachleitner-Hofmann, Barbara Pichler-Gebhard, Margarethe Rudas, Michael Gnant, Susanne Taucher, Daniela Kandioler, Elisabeth Janschek, Peter Dubsky, Sebastian Roka, Emanuel Sporn, Raimund Jakesz

Clin Cancer Res (2002) 8 (11): 3427–3432.

Published: 01 November 2002

View article

Journal Articles

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, Hubert Hausmaninger, Werner Kwasny, Michael Gnant, Raimund Jakesz, Ernst Kubista, Peter Birner, Georg Oberhuber, the Austrian Breast Colorectal Cancer Study Group

Clin Cancer Res (2002) 8 (6): 1831–1837.

Published: 01 June 2002

View article

Journal Articles

Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Peter Birner, Georg Oberhuber, Josephine Stani, Cornelia Reithofer, Hellmut Samonigg, Hubert Hausmaninger, Ernst Kubista, Werner Kwasny, Daniela Kandioler-Eckersberger, Michael Gnant, Raimund Jakesz, the Austrian Breast & Colorectal Cancer Study Group

Clin Cancer Res (2001) 7 (6): 1669–1675.

Published: 01 June 2001

View article

NARROW

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response

The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor–Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8

Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor–positive Early Breast Cancer: Results from the ABCSG Trial 5

Prognostic Value of EndoPredict in Women with Hormone Receptor–Positive, HER2-Negative Invasive Lobular Breast Cancer

Prediction of Distant Recurrence Using EndoPredict Among Women with ER⁺, HER2⁻ Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)

Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast Cancer Brain Metastases

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer

Abstract B28: Validation of a combined 13 gene six protein blood signature for earlier detection of ovarian cancer.

The PAM50 Risk-of-Recurrence Score Predicts Risk for Late Distant Recurrence after Endocrine Therapy in Postmenopausal Women with Endocrine-Responsive Early Breast Cancer

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Anemia Is a Significant Prognostic Factor in Local Relapse-Free Survival of Premenopausal Primary Breast Cancer Patients Receiving Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil Chemotherapy

Her2 and Progesterone Receptor Status Are Not Predictive of Response to Fulvestrant Treatment

Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only